| Mepha Pharma AG - Paliperidon-Mepha i.m. 150 mg, Depot-Injektionssuspension in einer Fertigspritze |
| 67852 | | 05 | | Paliperidon-Mepha i.m. 150 mg | | Depot-Injektionssuspension in einer Fertigspritze | | N05AX13 | | Paliperidone | | 16.10.2020 | | |
|
| Composition |
| paliperidonum 150 mg ut paliperidoni palmitas, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile ad suspensionem pro 1.5 ml corresp. natrium 5.5 mg. |
| Packungsbestandteile |
| Retardsuspension | | | | | | Active Agent | Dose |
|---|
| Paliperidonum | 150 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Disodium Phosphate | | Macrogol | | Sodium Dihydrogenophosphate Monohydrate | | Sodium Hydroxide | | Polysorbatum 20 |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
